Acute kidney injury in cirrhosis. - Wikidata - awgldk - TriplyDB

Acute kidney injury in cirrhosis.

Acute kidney injury in cirrhosis.

http://www.wikidata.org/entity/Q37323711

about

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h Acute Kidney Injury in Patients with Cirrhosis Hepatorenal syndrome: Update on diagnosis and treatment Neutrophil Gelatinase Associated Lipocalin (NGAL) - a biomarker of renal dysfunction in patients with liver cirrhosis: Do we have enough proof?Creatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-Analysis Management options in decompensated cirrhosis Acute kidney injury in patients with chronic liver disease Acute-on-chronic liver failure Treatment and management of ascites and hepatorenal syndrome: an update Outcomes of liver transplantation in patients with hepatorenal syndrome Acute kidney injury and post-reperfusion syndrome in liver transplantation Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.No sustained impact of intermittent extracorporeal liver support on thrombocyte time course in a randomized controlled albumin dialysis trial.Urinary biomarkers of acute kidney injury in patients with liver cirrhosis.Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma.Bile Cast Nephropathy in Patients with Acute Kidney Injury Due to Hepatorenal Syndrome: A Postmortem Kidney Biopsy Study Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis.Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal.Renal dysfunction in chronic liver disease.Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice.Renal dysfunction in patients with cirrhosis: Where do we stand?Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B.Risk models and scoring systems for predicting the prognosis in critically ill cirrhotic patients with acute kidney injury: a prospective validation study.The roles of albumin levels in head and neck cancer patients with liver cirrhosis undergoing tumor ablation and microsurgical free tissue transfer.Hepatitis B learning needs assessment of family medicine trainees in Canada: results of a nationwide survey.A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements.Hepatorenal syndrome: aetiology, diagnosis, and treatment.Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis.Renal dysfunction in cirrhosis.New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.Renal impairment in cirrhosis unrelated to hepatorenal syndrome Corticomedullary differentiation on T1-Weighted MRI: comparison between cirrhotic and noncirrhotic patients.Urine neutrophil gelatinase-associated lipocalin: a diagnostic and prognostic marker for acute kidney injury (AKI) in hospitalized cirrhotic patients with AKI-prone conditions.Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels.Association of AKI with mortality and complications in hospitalized patients with cirrhosis Relevance of New Definitions to Incidence and Prognosis of Acute Kidney Injury in Hospitalized Patients with Cirrhosis: A Retrospective Population-Based Cohort Study The Effect of Renal Function Impairment on the Mortality of Cirrhotic Patients: A Nationwide Population-Based 3-Year Follow-up Study.Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B.Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria

P2860

Q26770382-B76F3103-0476-452C-97A3-00C5A5FA68B6 Q26775643-F72C8F9C-C89F-4086-8B37-5CF7275A8E11 Q26777608-C9EFC003-F32A-423E-B2CD-05753E4DB5B5 Q26781488-7136669B-0E52-4530-8B95-1AE3D7498DF7 Q26795734-0ABD3AE9-7FD4-467A-AD6F-7225B4510C28 Q26800238-07BCEF96-E490-44E4-AD4B-20FDAEFE5455 Q26824834-9DB7B97F-6F81-4B49-AAFF-F3AED386DA0B Q26859067-0F963E75-000A-47DC-9986-28BD1D675324 Q27000268-9C3DA0E1-E591-4138-85B0-3E100E4E47DE Q28068506-370DEE2E-017B-4A35-A59C-5C2BB2316232 Q28074228-3E27A9D6-FD60-42EA-A4C4-63DDE631E79D Q30251763-8B0D50CD-352F-4F7D-85F4-1DFF6B092BC2 Q33417539-2E6D9658-188D-498C-869C-7467EAD90676 Q33710890-65445117-7700-4F9C-9796-133FD7EE6B07 Q33786571-9808B43C-1E1E-49AE-AAE1-38A8742D9323 Q33802797-016F0E25-EF28-486F-A2EB-09FACDA6ACFE Q33805260-9F61C6E8-27D3-4817-B187-3D85C75B829F Q33811643-3658D10F-1240-46A9-9758-48EE4B614518 Q33905612-603F4B35-2F79-4BA5-A844-33ED4618A928 Q33918950-A765BC4B-1CD5-4EDE-9E22-12C2A04FCDD1 Q34037360-1FDD4844-86C5-464B-ABCC-4A951C23AD01 Q34047665-4D526042-BD21-4EE6-A021-70D0801FA3BE Q34409132-A47D1D11-40D9-465B-9079-3FC438B1D80E Q34510762-FB497879-F8C0-4257-A72B-692FA72EBF01 Q34534396-415297B4-1014-4535-97C9-C3B404BFF4FE Q34789005-08768B9D-51B1-4BCC-9234-41DB74EED59C Q34873261-9DCF23FD-897E-48CB-A95B-B458A62CC2AF Q35012890-8B37ECCD-3299-488B-8E2F-9FB5C1694676 Q35534087-9FD78D62-FD6B-4331-B0C1-3484A79184CB Q35559713-E9D35D49-0A7C-4557-8E6E-11C8BF17DE45 Q35565646-22FDC913-BE0E-490F-9361-DCBD2A4B7A64 Q35742662-DE8157FC-8E13-4ADD-82EC-BA249CC2D54F Q35745335-77E44E29-779A-4D4D-A256-27D882F4F266 Q35810852-DAEE52E9-6F3D-4D4C-9B04-3BD53477D0FA Q35833124-C3387DFC-26C2-47C6-9B23-D78F39BE9947 Q36078269-C88F0F9A-42ED-4F61-9C92-E0D13DE64BBE Q36098647-41ABACAF-6D84-447A-9D9C-666D2F08B7EF Q36133714-7AE6BAA0-2DF5-4EBE-AE26-26C40A2CD1A9 Q36223439-755099B2-19DF-4FFF-A073-868110419572 Q36299428-7A6EEBE8-E014-4814-BE72-13605E0776FC

P2860

Acute kidney injury in cirrhosis.

http://www.wikidata.org/entity/Q37323711

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Acute kidney injury in cirrhosis.

@en

Acute kidney injury in cirrhosis.

@nl

type

label

Acute kidney injury in cirrhosis.

@en

Acute kidney injury in cirrhosis.

@nl

prefLabel

Acute kidney injury in cirrhosis.

@en

Acute kidney injury in cirrhosis.

@nl

P1433

Q37323711-A2BC29BF-1C9B-4177-83A4-5CBF1FB17347

P1476

Q37323711-251022AD-5D4A-4463-B881-77245591C659

P2093

Q37323711-6DFC57C5-E464-4484-AB5D-759210CD3984

Q37323711-B8431CD6-F134-42CC-83AE-FF18D717423E

Q37323711-CCD52A9D-CC95-4DFB-AC41-BD549A708766

P2860

Q37323711-023F3ADA-293B-4E8A-AC9D-D06B1DA2C36A

Q37323711-09E39BCD-31CB-48A8-9BD0-62514B72B8CB

Q37323711-0ECEC803-189C-4580-8687-DD846A642359

Q37323711-0F97AAAF-B164-4709-BF38-8162935C23A6

Q37323711-13A6CF14-938D-4187-90EB-F738ECA37EF3

Q37323711-180EE05A-FA66-4B4D-926C-6E0B5AAA7F9B

Q37323711-1AC50ED6-C7F7-4402-851F-6F8079FB6274

Q37323711-1C57DBEF-F9D7-44B4-B91A-F7DB644048ED

Q37323711-210D950E-9EF9-4580-9577-73CD307F4E56

Q37323711-22BDCB0E-24AF-4E8B-A02B-D24CFDD16360

P304

Q37323711-75BF99B9-B122-43F1-9493-ABA136B2A1F4

P31

Q37323711-F79F70F2-6BCD-4134-B315-80E93E772620

P356

Q37323711-B81F9608-82D5-4990-9693-049897C9F7AB

P407

Q37323711-ADBC4980-D8AC-4EED-8BB3-60E7AFEC090B

P433

Q37323711-AE6F53EB-F7D8-4172-A3BF-460BAE892C93

P478

Q37323711-DB0F9000-5CBA-4F1E-A648-1F75BC59FA89

P577

Q37323711-951CD625-7CEA-4EE5-8428-E7027F7B8893

P5875

Q37323711-ED8907BE-9B40-451E-AD0A-FC18318ACD56

P698

Q37323711-94F039B8-9219-4910-93DB-2A85FD44D4C3

P356

P1433

P1476

Acute kidney injury in cirrhosis.

@en

P2093

Antonella Viola

http://www.w3.org/2001/XMLSchema#string

Chirag R Parikh

http://www.w3.org/2001/XMLSchema#string

Guadalupe Garcia-Tsao

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats.

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.

Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

P304

2064-2077

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22605

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23468323

http://www.w3.org/2001/XMLSchema#string

P698

19003880

http://www.w3.org/2001/XMLSchema#string